Serviços Personalizados
Journal
Artigo
Espanhol (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO
Links relacionados
Similares em
SciELO
Compartilhar
Permalink
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
versão impressa ISSN 2225-5109versão On-line ISSN 2227-4731
Resumo
SOSA FLORES, Jorge Luis e CHAPONAN MENDOZA, Juan Fernando. Antibiotic resistance of Escherichia coli, according to extended-spectrum beta-lactamase production, in urine cultures. Hospital III-1. Chiclayo, Peru 2020. Rev. Cuerpo Med. HNAAA [online]. 2022, vol.15, n.4, e1627. Epub 28-Jan-2023. ISSN 2225-5109. http://dx.doi.org/10.35434/rcmhnaaa.2022.154.1627.
Objective:
to determine the antibiotic resistance of Echerichia coli, in urine cultures, according to ESBL production, in hospitalized patients.
The study:
Descriptive-retrospective design. Bacterial identification was done with VITEK XL, susceptibility, with the CLSI M100 guidelines. 30 edition.
Findings:
E. coli ESBL positive, presented 0% resistance to: Meropenem, ertapenem, tigecycline and colistin. Piperacillin/tazobactam, nitrofurantoin, imipenem, amikacin with 16.7%, 6.2%, 5% and 1% respectively. E. Coli ESBL negative, presented 0% resistance to: cefotaxime, cefuroxime, tigecycline and piperacillin/tazobactam. Ceftriaxone, cefepime, gentamicin, cefazolin, ceftazidime, nitrofurantoin, meropenem, amikacin, imipenem, and ertapenem with 14.7%, 13%, 13%, 10.7%, 9.7%, 9.1%, 9.1%, 8%, 5%, 2.7%, respectively.
Conclusion:
Meropenen, ertapenem, tigecycline, cholesterol, piperacillin/tazobactam, nitrofurantoin, amikacin and imipenem, with less than 20% resistance, were the same for ESBL-positive E. coli, and E. coli, without considering ESBL production.
Palavras-chave : Antibiotic Resistance; Escherichia coli; Extended-spectrum beta-lactamases; Urine culture.
